These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10445270)

  • 41. [Pharmaceutical care of a patient with acute diabetic foot syndrome].
    Kaufmann D; Walkenbach K; Döhler N; Wagemann G; Menzen M; Homann J; Jaehde U
    Med Monatsschr Pharm; 2011 Feb; 34(2):55-60. PubMed ID: 21428016
    [No Abstract]   [Full Text] [Related]  

  • 42. Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome.
    Simson U; Nawarotzky U; Friese G; Porck W; Schottenfeld-Naor Y; Hahn S; Scherbaum WA; Kruse J
    Diabet Med; 2008 Feb; 25(2):206-12. PubMed ID: 18290863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hemostatic studies in decompensated diabetes mellitus].
    Petrunova N; Genova V
    Vutr Boles; 1988; 27(5):43-6. PubMed ID: 3213038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased prevalence of elevated urinary albumin excretion rate in type 2 diabetic patients suffering from ischemic foot lesions.
    Zander E; Heinke P; Gottschling D; Zander G; Strese J; Herfurth S; Michaelis D
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():51-3. PubMed ID: 9288546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of thrombosis and hemostasis by antithrombin.
    Sakuragawa N
    Semin Thromb Hemost; 1997; 23(6):557-62. PubMed ID: 9469630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular factors involved in the development of diabetic foot syndrome.
    Bruhn-Olszewska B; Korzon-Burakowska A; Gabig-Cimińska M; Olszewski P; Węgrzyn A; Jakóbkiewicz-Banecka J
    Acta Biochim Pol; 2012; 59(4):507-13. PubMed ID: 23251910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetes self-management, fasting blood sugar and quality of life among type 2 diabetic patients with foot ulcers.
    Navicharern R
    J Med Assoc Thai; 2012 Feb; 95(2):156-62. PubMed ID: 22435243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diabetic gangrene as the prime manifestation of diabetes mellitus].
    Vareka T; Zapletalová J; Zeman M
    Cas Lek Cesk; 2004; 143(11):774-8. PubMed ID: 15628575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In This Issue….
    Sellers E
    Can J Diabetes; 2020 Apr; 44(3):211. PubMed ID: 32241554
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of stypturon on hemorrhagic tendency increased by anticoagulants].
    VODOPIVEC M
    Klin Wochenschr; 1954 Dec; 32(47-48):1112. PubMed ID: 13234295
    [No Abstract]   [Full Text] [Related]  

  • 51. Case of Diabetes Mellitus with Very Low Specific Gravity.
    Macphail JM
    Ind Med Gaz; 1898 Jan; 33(1):20. PubMed ID: 29001710
    [No Abstract]   [Full Text] [Related]  

  • 52. [Triple-blind clinical trial with placebo control to evaluate the efficacy of a heparin of low molecular weight (bemiparin) for treating slow-responding ulcers in diabetic foot in primary care].
    Rullán M; Cerdà L; Frontera G; Llobera J; Masmiquel L; Olea JL
    Aten Primaria; 2003 May; 31(8):539-44. PubMed ID: 12765594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Specific aspects of heparin action on hemostatic reaction in patients with type II diabetes mellitus before and after the foot surgery].
    Harbarchuk OI; Malyzhev VO
    Klin Khir; 2001 Aug; (8):6-8. PubMed ID: 11794120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Status of the system of hemostasis in patients with non-insulin-dependent and insulin-dependent diabetes mellitus without clinical manifestation of vessel pathology].
    Harbarchuk OI
    Ukr Biokhim Zh (1978); 1998; 70(4):134-9. PubMed ID: 9848216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Monitoring of anticoagulants of secondary haemostasis].
    Schuster B
    Hamostaseologie; 2009 Aug; 29(3):268-73. PubMed ID: 19644600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effect of heparin on the functioning of the hemostasis system in patients with insulin-dependent diabetes mellitus in severe forms of diabetic foot].
    Garbaruchuk OI; Malyzhev VO
    Ukr Biokhim Zh (1978); 1998; 70(5):111-6. PubMed ID: 10445270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cytokine profile and fibrinogen level in blood plasma in diabetic foot under the action of heparin].
    Harbarchuk OI
    Ukr Biokhim Zh (1999); 2000; 72(3):118-9. PubMed ID: 11200464
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.